Trial Profile
An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2012
Price :
$35
*
At a glance
- Drugs Patupilone (Primary) ; Midazolam; Omeprazole
- Indications Solid tumours
- Focus Pharmacodynamics
- Sponsors Novartis
- 23 Apr 2012 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
- 23 Apr 2012 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
- 26 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.